Thursday, 20 June 2019

CRO News

  • Merck confirms shutting Bangalore Genei facility

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2015

    The company confirmed with BioSpectrum that the production at the facility had been stopped since July 31, 2015, and that the decommissioning activities are in progress. As part of Merck M...Read more

  • PPD recognized for excellence in Clinical Research

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2015

    Pharmaceutical Product Development, LLC (PPD) has announced that it has been recognized for excellence in clinical research by pharmaceutical and biotechnology company executives surveyed f...Read more

  • PAREXEL announces services agreement with Pfizer

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2016

    PAREXEL a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will contin...Read more

  • Global bioabsorbable scaffolds market to rocket beyond $2 bn by 2021

    CRO |  Features | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2015

    The global market value for bioabsorbable scaffolds (BAS) will expand rapidly from $143.7 million in 2014 to just under $2.1 billion by 2021, driven primarily by new product approvals and a...Read more

  • Quintiles, DaVita Clinical Research announce strategic alliance

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2016

    Quintiles, and DaVita Clinical Research, a wholly-owned subsidiary of DaVita HealthCare Partners Inc., a leader in kidney care, has announced a global strategic alliance. The alliance combi...Read more

  • PAREXEL to acquire Health Advances

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2016

    PAREXEL International Corporation has announced that the company has entered into a definitive agreement to acquire all outstanding equity securities of Health Advances, an independent life...Read more

  • ICON launches Electronic Informed Consent

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2015

    ICON has announced the launch of Firecrest eConsent, a next-generation electronic informed consent solution that incorporates key recommendations from the FDA's recent draft guidance on inf...Read more

  • We are a niche protein research services company: Dr Kundu

    CRO |  News | By Rahul Koul Koul | 0 Comment | 17 May, 2013

    "The global CRAMS scenario has been very competitive, complex and cyclical. We are dependent on the success of the molecule moving from research to process development and then preclinical ...Read more

  • SGS Life Science's Mumbai facility witnesses completion

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2015

    An official opening of this state-of-the-art laboratory is planned for May 20, 2015. The expansion has seen the previous 1,393 square meter laboratory space more than double in size to 3,40...Read more

  • Quintiles among Fortune 500 list of most admired companies in 2015

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2015

    Quintiles, the world's largest biopharmaceutical services company, has been named to FORTUNE magazine's "World's Most Admired Quintiles is ranked third overall in FORTUNE's Healthcare: Phar...Read more

  • Confidence building measures must for clinical trials in India: Experts

    CRO |  News | By Rahul Koul Koul | 0 Comment | 24 Jul, 2015

    The Indian Society for Clinical Research (ISCR) has stated that in the recent times, several steps have been taken by the Indian regulators to bring clinical research in India back on track...Read more

  • Quintiles wins best CRO award at World Vaccine Congress 2015

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2015

    After being named as one of America's best employers by Forbes, Quintiles, for the third time in the last four years has been named the best clinical research organization (CRO) at the Vacc...Read more

  • Tighter clinical trial regulation is need of the hour

    CRO |  Features | 0 Comment | 11 Feb, 2013

    Recently, the Supreme Court managed to stir the $600 million (Rs 3,246 crore) Indian bioservices industry, when it asked for greater accountability from the Drug Controller General of India...Read more

  • Quintiles, Quest Diagnostics form JV

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

    Quintiles and Quest Diagnostics announced a definitive agreement to form a global clinical trials laboratory services business. The transaction, which is subject to standard and customary c...Read more

  • PPD achieves CEO Cancer Gold Standard Reaccreditation

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

    Pharmaceutical Product Development (PPD) has announced that it has achieved the CEO Cancer Gold Standard reaccreditation from the non-profit CEO Roundtable on Cancer for maintaining a stron...Read more

  • Quintiles offers a new solution to BioPharma Cos

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2015

    To help emerging biopharmaceutical companies in the Asia Pacific region, achieve their growth aspirations, Quintiles has launched a new solution set. It is tailored to meet the needs of eme...Read more

  • Theorem opens a new clinical supplies facility

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2015

    Theorem Clinical Research will open a new, state-of-the-art clinical supplies facility in Frankfurt, Germany, in June. The current good manufacturing practice (cGMP) compliant facility will...Read more

  • Quintiles most preferred CRO for phase II/III trials

    CRO |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2013

    A recent report has indicated that Quintiles best differentiates itself on service quality in phase II/III clinical research. The Industry Standard Research's (ISR) 2013 CRO Quality Benchma...Read more